All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 16, 2022
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for April 27, 2022

April 27, 2022
No Comments
Biopharmas raising money in public or private financings, including: Apertura Gene Therapy, Cellectis, Cytovia, Deciphera, Dermata, Hemoglobin Oxygen, NLS, Okyo, Quantum Genomics, RVAC Medicines, Scynexis, Tempest.
Read More
Biovitals platform on computer, smartphone

Biofourmis lands $300M series D to fuel DTx, virtual care offerings

April 26, 2022
By Meg Bryant
No Comments
Biofourmis Inc. secured $300 million in a series D financing led by General Atlantic, with participation by CVS Health and existing investors. The round lifted the Boston-based company’s valuation to more than $1 billion and unicorn status, according to executives. Biofourmis will use the funds to drive next-stage growth in its virtual care offerings and digital therapeutics (DTx).
Read More

Financings for April 26, 2022

April 26, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Biotech Group Acquisition, Hillevax, Oncoquest, Quest Pharmatech, Takeda.
Read More

Financings for April 26, 2022

April 26, 2022
No Comments
Med-tech firms raising money in public or private financings, including: Establishment Labs.
Read More

Financings for April 26, 2022

April 26, 2022
No Comments
Biopharmas raising money in public or private financings, including: Clarus, Nkarta, Sunshine, Valneva.
Read More
Cancer immunotherapy illustration

Epitopea closes $14M seed round for tumor antigen discovery

April 25, 2022
By Cormac Sheridan
No Comments
Epitopea Ltd. raised $13.6 million in seed financing to take forward a new cancer immunotherapy platform based on the identification of a new class of tumor-specific antigens encoded by non-canonical genomic sequences.
Read More

Cambridge Innovations raises £225M fund amid high interest in university spinouts

April 25, 2022
By Nuala Moran
No Comments
Cambridge Innovation Capital (CIC) has closed its oversubscribed Fund II at £225 million (US$287 million) and is moving from its previous model of open-ended investing to a traditional fixed-term venture capital fund. The money will be dedicated to spinouts from Cambridge University, with CIC investing in series A rounds, but also following on as companies mature and their capital requirements increase.
Read More

Financings for April 25, 2022

April 25, 2022
No Comments
Med-tech firms raising money in public or private financings, including: Signal 1, Stentit.
Read More

Financings for April 25, 2022

April 25, 2022
No Comments
Biopharmas raising money in public or private financings, including: Exogene, Forcefield, Healome, Hemostemix, Hillevax, Immunocore, Mitorx, Salarius, Savara, Scynexis, Syncona, Takeda.
Read More

Financings for April 22, 2022

April 22, 2022
No Comments
Med-tech firms raising money in public or private financings, including: Bioconnection.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 291 292 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 13.
  • Hearing ear icon

    Cochlear to acquire rival Oticon Medical for $121M

    BioWorld MedTech
    Cochlear Ltd. will acquire Danish hearing implant company Oticon Medical A/S for AU$170 million (US$121 million) after parent company the Demant Group said it...
  • Illustration of cancer cells and immunotherapy treatment

    Former Genentech execs launch new immunotherapy biotech LTZ Therapeutics

    BioWorld
    After raising $17 million in seed funding, immunotherapy-focused biotech company, LTZ Therapeutics Inc., is announcing plans for the fledgling company whose...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing